MTX

Links shared publicly online about this topic

Antares initiates dosing in VIBEX MTX clinical study for rheumatoid arthritis

news-medical.net — “Antares Pharma, Inc. today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX product which is being developed for the treatment of rheumatoid arthritis. The clinical study will evaluate several dose strengths of VIBEX MTX delivered with a proprietary autoinjector versus conventional needle and syringe administration by a healthcare professional.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 2, 2011 at 8:52 am By:

RA_Wisdom OrganizedWisdom RA OW Health

Antares initiates dosing in VIBEX MTX clinical study for rheumatoid arthritis: Antares Pharma, Inc. today announ... http://bit.ly/ejKqHB

1 year ago...

Antares Pharma Announces Positive Study Results with VIBEX™ MTX in Rheumatoid Arthritis Patients | Business Wire

businesswire.com — “Antares Pharma, Inc. (NYSE Amex: AIS) today announced the positive results of a clinical study evaluating VIBEX™ MTX, a proprietary auto injectoView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on August 5, 2011 at 3:32 am By:

RA_Wisdom OrganizedWisdom RA OW Health

Antares Pharma Announces Positive Study Results with VIBEX™ MTX in Rheumatoid Arthritis Patients: EWING, N.J.--(... http://bit.ly/qZk7JF

6 months ago...

Antares Pharma Announces First Rheumatoid Arthritis Patient Dosed in VIBEX™ MTX Clinical Trial | Business Wire

businesswire.com — “Antares Pharma, Inc. (NYSE Amex: AIS) today announced that the first patient has been dosed in a clinical study evaluating the VIBEX™ MTX producView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on February 1, 2011 at 2:46 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

Antares Pharma Announces First Rheumatoid Arthritis Patient Dosed in VIBEXâ„¢ MTX Clinical Trial: EWING, N.J.--(BU... http://bit.ly/eDM5cT

1 year ago...

BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission

news-medical.net — “BSD Medical Corporation today announced that it has received review questions from the U.S. Food and Drug Administration (FDA) regarding the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 12, 2010 at 5:46 pm By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: BSD receives FDA review questions for Phase II MTX-180 Microwave Ablation System 510(k) submission:... http://bit.ly/asnM3a

2 years ago...

BSD Medical files 510(k) submission for premarket clearance of Phase II MTX-180

news-medical.net — “BSD Medical Corporation today announced that the Company has filed a 510(k) submission with the U.S. Food and Drug Administration for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System for ablation of soft tissue.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 22, 2010 at 4:59 pm By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: BSD Medical files 510(k) submission for premarket clearance of Phase II MTX-180: BSD Medical Corpor... http://bit.ly/cZy8WB

2 years ago...

Antares Pharma Announces Positive Study Results With Vibex Mtx in Rheumatoid Arthritis Patients - Drugs.com MedNews

drugs.com — “Antares Pharma, Inc. (NYSE Amex AIS) today announced the positive results of a clinical study evaluating VIBEX MTX, a proprietary auto injector product designedView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 5, 2011 at 5:16 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Antares Pharma Announces Positive Study Results With Vibex Mtx in Rheumatoid Arthritis Patients: --NEW PAT... http://bit.ly/omC7jQ #drug

6 months ago...

Antares Pharma Announces Positive Study Results with VIBEX MTX in Rheumatoid Arthritis Patients - Drugs.com MedNews

drugs.com — “Aug 4, 2011 - Antares Pharma, Inc. (NYSE Amex AIS) today announced the positive results of a clinical study evaluating VIBEX MTX, a proprietary auto injector prView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 4, 2011 at 3:15 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Antares Pharma Announces Positive Study Results with VIBEX MTX in Rheumatoid Arthritis Patients: --New Pat... http://bit.ly/qz7MEz #drug

6 months ago...

@hottstuffbanta It's the most common dmard. Some info here & comments from patients http://bit.ly/pIWE2c #mtx

rawarrior.com — “Articles tagged with 'Methotrexate' at Rheumatoid Arthritis WarriorView full resource at rawarrior.com

  • View Related
  • Share

Most Recently Shared on July 17, 2011 at 7:57 pm By:

Kelly_Young Kelly Young ePatient

@hottstuffbanta It's the most common dmard. Some info here & comments from patients http://bit.ly/pIWE2c #mtx

7 months ago...

My dad asked me if my Enbrel and MTX bandaids were tattoos. Uh, no. #spoonie ... / NessiehasPSA / Brizzly

brizzly.com — “A Brizzly PictureView full resource at brizzly.com

  • View Related
  • Share

Most Recently Shared on June 1, 2011 at 3:27 am By:

Trial of Low-Dose MTX and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma - Full Text View - ClinicalTrials.gov

clinicaltrials.gov — “Trial of Low-Dose MTX and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma - Full Text View - ClinicalTrials.govView full resource at clinicaltrials.gov

  • View Related
  • Share

Most Recently Shared on July 11, 2011 at 2:43 pm By:

Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF

hgsi.com — “Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNFView full resource at hgsi.com

  • View Related
  • Share

Most Recently Shared on March 10, 2011 at 1:06 am By:

LupusMD Lupus Doctor Physician, Doctor, Internist, and Rheumatologist

Benlysta approved:good news 4 patients w/ mild SLE, joint,skin problems despite prednisone plaquenil and MTX,AZA or MMF http://bit.ly/gTKKNF

11 months ago...

BSD Medical Receives FDA 510(k) Clearance To Market The MicroThermX Microwave Ablation System

medicalnewstoday.com — “BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave AblView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 20, 2010 at 3:00 pm By:

mnt_cancer MNT Cancer News Health News

BSD Medical Receives FDA 510(k) Clearance To Market The MicroThermX Microwave Ablation System http://mnt.to/3HD4 #cancer

1 year ago...

Immune Responses To Tetanus Vaccine Unchanged For RA Patients On Rituximab

medicalnewstoday.com — “Researchers from johns hopkins university determined that immune responses to the tetanus vaccine were not changed when rituximab in combination with methotrexate (mtx) was compared with mtx aloneView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 7, 2010 at 12:17 pm By:

mnt_arthritis MNT Arthritis News Health News

Immune Responses To Tetanus Vaccine Unchanged For RA Patients On Rituximab http://mnt.to/3vZR

2 years ago...

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis - Drugs.com MedNews

drugs.com — “European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment oView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 8, 2010 at 10:40 am By:

RA_Wisdom OrganizedWisdom RA OW Health

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after... http://bit.ly/annWwg

2 years ago...

Etanercept Helps Restore Normal Growth In Children With Juvenile Arthritis

medicalnewstoday.com — “Significant Increase in Height, Weight, and BMI Percentiles Achieved With and Without Methotrexate.Researchers from the Cincinnati Children's Hospital Medical Center observed a statisticaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 4, 2010 at 2:07 pm By:

mnt_pediatrics MNT Pediatrics News Pediatrics and Health News

Etanercept Helps Restore Normal Growth In Children With Juvenile Arthritis http://mnt.to/3M5f #pediatrics

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390